HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever Targets Sustainable Palm Oil Alternative With $120m Biotech Deal

Executive Summary

Unilever PLC partners with biotechnology company Genomatica to fund and scale plant-based alternatives to palm oil for personal care and cleaning products.

You may also be interested in...



L’Oreal Joins Heavyweights Tackling Sustainable Surfactants With Geno Biotech

L’Oreal, Kao and Unilever have partnered with Genomatica, Inc. (Geno) to develop sustainable surfactants by replacing feedstocks such as palm oil and fossil fuels with biotech alternatives.

Cosmetic Ingredients That Could Be Hard To Get In 2023

Beauty and personal-care product manufacturers should expect continued supply chain issues in 2023, supplier execs said at the IBA Supply Chain and Sustainability Virtual Summit, highlighting a number of ingredients and materials that could face particular challenges.

P&G’s Moeller Withstands NGO Charges Of Environmental Foot-Dragging, Stays Board Chair

Procter & Gamble Co. shareholders elected 10 incumbent directors and one new director to the company’s board on 11 October, each receiving more than 90% of votes, the company says. NGOs pushed for changes, including CEO Jon Moeller’s replacement with an independent director, citing rising concerns about P&G’s forest sourcing practices.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel